首页> 美国卫生研究院文献>The Neurohospitalist >Neurological Prognostication of Cardiac Arrest in an Era of Extracorporeal Membrane Oxygenation
【2h】

Neurological Prognostication of Cardiac Arrest in an Era of Extracorporeal Membrane Oxygenation

机译:体外膜氧合时代心脏骤停的神经学预后

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A neuron-specific enolase level greater than 33 ng/mL at days 1 to 3 or status myoclonus within 1 day are traditional indicators of poor neurological prognosis in survivors of cardiac arrest. We report the case of a 70-year-old man who received extracorporeal membrane oxygenation following cardiac arrest. Despite having both an elevated neuron-specific enolase concentration of 68 ng/mL and status myoclonus, he made an excellent neurological recovery. The value of traditional markers of poor prognosis such as elevated neuron-specific enolase or status myoclonus has not been systematically validated in patients treated with extracorporeal membrane oxygenation or therapeutic hypothermia. Straightforward application of practice guidelines in these cases may result in tragic outcomes. This case underscores the need for reliable prognostic markers that account for recent advances in cardiopulmonary and neurological therapies.
机译:在第1至第3天,神经元特异性烯醇酶水平大于33 ng / mL,或在1天之内处于肌阵挛状态,这是心脏骤停幸存者神经系统预后不良的传统指标。我们报道了一名70岁的男子在心脏骤停后接受体外膜氧合的情况。尽管神经元特异性烯醇化酶的浓度升高,达到68 ng / mL,肌阵挛状态也得到改善,但他的神经功能恢复良好。传统的不良预后标志物(例如神经元特异性烯醇化酶升高或肌阵挛状态升高)的价值尚未得到体外膜氧合或低温治疗的患者的系统验证。在这些情况下直接应用实践准则可能会导致悲剧性后果。该病例强调需要可靠的预后标志物,以说明心肺和神经治疗的最新进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号